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Highlights 
 Pain seems to be associated with worse cognition in cross-sectional studies.   
 In our study, after 4 years of follow-up, pain was not associated with worse cognition. 
 Only severe pain was associated with worsening in memory.  
 
 
ABSTRACT  
The finding of a potential association between pain and cognitive decline is limited to a few cross-
sectional studies with relatively samples. We therefore aimed to investigate whether the presence 
and severity of pain at baseline could predict a decline in cognitive function over four years of 
follow-up in the English Longitudinal Study of Ageing. At baseline, participants with no dementia 
who were “often troubled by pain” were considered to have pain. Pain severity was categorized as 
mild, moderate, or severe. Cognitive function was explored through verbal fluency (assessed by 
asking how many different animals the participants could name in 60 seconds), memory (sum of 
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immediate and delayed verbal memory) and processing speed (number of target letters correctly 
identified on the letter cancellation task). Multivariable linear regression was used (exposure: pain; 
outcomes: cognitive change between follow-up and baseline, based on standardized residuals). 
Altogether, 6,515 community-dwelling people with a mean age of 65 years (women=57.3%) were 
included. Over a 4-year follow-up, after adjusting for 26 potential confounders, no association 
between pain (yes vs. no) and verbal fluency (beta=0.02; 95%CI: -0.15 to 0.18), memory (0.05; 
95%CI: -0.28 to 0.38), or processing speed (0.55; 95%CI: --18.4 to 2.93) at follow-up was found. 
Only severe pain was associated with greater decline in memory (-0.36; 95%CI: -0.68 to -0.04). In 
conclusion, in older people, pain was not associated with worsening in cognition, except for severe 
pain, which was marginally associated with worsening in memory tests. Further longitudinal studies 
are needed to confirm or refute our findings.  
 
Keywords: pain; memory; cognitive decline; elderly. 
INTRODUCTION 
Pain is a frequently reported symptom, with over half of older adults experiencing pain.[1] Pain is 
associated with a range of adverse outcomes in older age, including a deterioration of activities of 
daily living, physical and mobility disability[2, 3], low physical activity [4], falls[5], fear of 
falling[6] and frailty.[7],[8] It has been hypothesized that the increased risk of falls and subsequent 
mobility limitation in older people with pain may partly be attributed to impaired cognition.[9-11]  
 
Whilst research has started to consider the impact of pain on cognition in older age, it has been 
limited by small samples,  cross-sectional designs, and a small number of tests assessing cognitive 
functioning.[9-14] Thus, it remains unclear whether pain is associated with various important 
subdomains of cognition. One recent study with a large cohort of American participants found that 
persistent pain was associated with a more rapid memory decline and with a moderate increase in 
the incidence of dementia compared with those without persistent pain.[15] Although this study 
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helps advance our understanding of the link between pain and the onset of poor cognitive status, 
some important confounders known to influence cognition in older age (such as physical 
activity[16]) were not assessed. Moreover, only six comorbidities were included, and thus some 
important causes of pain and/or cognitive decline in the elderly were not considered.[15] Given the 
high levels of pain in older adults[17] and the need to identify potential modifiable risk factors for 
cognitive decline, it is important that robust longitudinal research considers this important question.   
 
Given this background, we aimed to explore whether the presence of pain at baseline could predict 
any decline in performance on several cognitive tests assessed in the English Longitudinal Study of 
Ageing (ELSA), an ongoing cohort study of community-dwelling older people, over four years of 
follow-up. In a secondary analysis, we explored whether the severity of pain is associated with 
declines in performance on cognitive tests.  
 
MATERIALS AND METHODS 
The survey 
The English Longitudinal Study of Ageing (ELSA) is a nationally representative longitudinal 
ongoing study of 11,050 people living in England aged 50 and over. The first assessment was 
conducted in 2002/3 with an extensive nurse visit every four years and a face-to-face interview 
every two years (http://www.elsa-project.ac.uk/). For the purposes of the present analyses, we used 
data from wave 2 (2004/2005) (baseline) and wave 4 (2008/2009), since these two waves included 
all the cognitive tests mentioned below.  
 
Participants gave full informed consent to participate in the study and ethical approval was obtained 
from the London Multi-center Research Ethics Committee.  
 
Exposure: pain    
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At baseline (wave 2), participants were asked if they were “often troubled by pain”. If they 
responded “no,” their response was coded as “no pain”. Those who responded affirmatively were 
asked to evaluate the intensity of their pain  as mild, moderate or severe.  
 
Outcome variables: changes in cognitive tests 
Cognitive function was evaluated in the ELSA through several tests. For our research, we included 
three domains of cognition, namely verbal fluency, memory and processing speed.[18] Verbal 
fluency was assessed by asking how many different animals the participants could name in 60 
seconds. Memory was calculated as the sum of immediate and delayed verbal memory. Specifically, 
to each participant, a list of 10 nouns was presented on a computer, one every 2 s. Participants were 
asked to recall as many words as possible immediately and again after a short delay during which 
they carried out the other cognitive tests. As a measure of processing speed, the score of the number 
of target letters correctly identified on the letter cancellation task was taken. Briefly, for this last 
task, participants were given a clipboard to which a page of 780 random letters of the alphabet set 
out in a grid of 26 rows and 30 columns was attached. The participant was asked to cross out as 
many target letters (P and W) as possible in 1 min. An example was given at the top of the page to 
show participants how to cross out the letters. Participants were asked to work across and down the 
page as if they were reading and to perform the task as quickly and accurately as possible.  
 
To calculate the degree of cognitive change between wave 4 and 2, we carried out a linear 
regression analysis using the values of each test at wave 2 as independent variables, and scores of 
cognitive tests at wave 4 as dependent variables and using the standardized residual as a measure of 
cognitive change.  
 
Other covariates 
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We considered several potential confounders in the association between pain and cognitive tests, 
other than age, sex, race: (1) education, descriptively reported as formal education (“some college” 
and “college and above”) vs. other (no education, high-school, high-school graduate); (2) marital 
status, categorized as married vs. others (not married, divorced, singles, not known); (3) smoking 
habits, categorized as current/former vs. never; (4) disability, categorized as having at least one 
difficulty in activities of daily living (ADL) vs. no difficulty; (5) body mass index (BMI), measured 
by a trained nurse; (6) self-reported physical activity, assessed by questions on the frequency of 
participation in vigorous, moderate and light physical activities (more than once per week, once per 
week, one to three times per month, hardly ever) and descriptively reported as high vs. other levels; 
(7) alcohol consumption, categorized as yes vs. no in the last week; (8) depressive symptoms, 
through an 8-item version of the CES-D[19]; (9) household wealth, calculated as total net non-
pension household wealth, which is a summary measure of the value of financial, physical and 
housing wealth owned by the household (i.e., a single respondent or a responding couple along with 
any dependent individuals) minus any debt. 
Medical conditions were defined according to whether participants were told by a doctor they had 
arthritis, osteoporosis, stroke, heart problems (heart attack, congestive heart failure, angina, acute 
myocardial infarction, arrhythmia), lung diseases (chronic lung disease or asthma), cancer, diabetes, 
high blood pressure/hypertension, or Parkinson’s disease. Information at baseline was used for all 
the above-mentioned covariates. 
 
Statistical analyses 
Normal distributions of continuous variables were tested using the Kolmogorov-Smirnov test. The 
data were normally distributed and therefore means ± standard deviations (SDs) were used to 
describe quantitative measures. Percentages were used for all discrete variables. For comparing 
descriptive characteristics by pain status (yes vs. no), continuous variables were compared using an 
independent Student’s test, whilst a chi-square test was used for categorical variables.  
AC
CE
PT
ED
 M
AN
US
CR
IPT
7 
 
 
The strength of the association between pain at baseline and cognitive changes occurring between 
waves 2 and 4 was assessed through a linear regression analysis in two models, one adjusted only 
for age and sex (basic) and one adjusted for all baseline factors known to be associated with poor 
cognition and significantly different between people with pain and those without, taking a p-value 
<0.10 as the inclusion criterion for both situations (fully adjusted multivariable model). Multi-
collinearity was assessed with the variance inflation factor (VIF), taking a cut-off of 2 for exclusion, 
but no covariate was excluded for this reason. The results were reported as betas with their 95% 
confidence intervals (CIs). We also reported the model’s fits as R2. 
 
In the secondary analyses, we assessed whether pain categorized according to its severity (i.e. mild, 
moderate, severe) could affect cognitive change using a linear regression analysis, reported as fully 
adjusted betas with 95% CIs.  
 
We performed several sensitivity analyses using as potential moderators of our results the median 
values for continuous variables and the original division for categorical parameters. However, none 
of the interaction terms between pain and these potential moderators was significant in predicting 
performance on cognitive tests at follow-up (all p-values >0.05). 
 
All analyses were done using the SPSS 21.0 for Windows (SPSS Inc., Chicago, Illinois). All 
statistical analyses were two-tailed, and a p-value <0.05 was assumed to be statistically significant. 
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RESULTS 
Study population 
In total, 9,432 participants took part at wave 2, of whom 8,960 had complete data on pain, cognitive 
function and the covariates.  Of these 8,960, we included 6,515 at wave 4 (2,187 were lost during 
the follow-up, 242 died between the surveys, and 16 participants received a diagnosis of dementia).   
 
The 2,445 participants excluded at wave 4 due to missing cognitive tests at follow-up or who had 
died were significantly older (67.8±11.8 vs. 65.0±9.7 years, p<0.0001) than those included 
(n=6,515). Moreover, the excluded participants were significantly more likely to have pain (42.2 vs. 
35.6%, p<0.0001) and scored worse in all the cognitive tests assessed at wave 2 (p<0.0001 for all 
comparisons).  
 
Baseline characteristics 
The mean±SD age of the 6,515 participants was 65.0±9.7 years (range: 52-90), with a slight 
majority of women (57.3%) and almost all white (98.1%).  
 
Table 1 shows the baseline characteristics of the 6,515 subjects by absence or presence of pain. 
Among the 2,317 participants who reported experiencing pain (35.6% of the baseline population), 
697 (=10.7% of baseline population), 1,166 (=17.9%) and 450 (=6.9%) reported mild, moderate and 
severe pain, respectively.   
 
As reported in Table 1, those reporting any pain were significantly older and more frequently 
women (p<0.0001 for both comparisons) than the 4,198 individuals not reporting pain at baseline. 
Moreover, a significantly smaller proportion of people with pain reported drinking alcohol in the 
last week or engaged in a high level of physical activity; also, the group reporting no pain had a 
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higher proportion of smokers but a much smaller proportion of disabled people were present (Table 
1).  
The participants with pain had a significantly higher prevalence of all the diseases investigated and 
reported higher depressive symptoms than those with no pain (Table 1). Finally, participants with 
pain had worse baseline scores than participants with no pain for verbal fluency and memory 
(p<0.0001 for both comparisons), but not for processing speed (p=0.64).  
 
Follow-up data 
Of the 2,317 participants experiencing pain at baseline, 1,492 had pain at wave 4 (64.4%), whilst 
among 4,198 participants who did not report pain at baseline, 852 had pain at wave 4 (20.3%). 
 
Table 2 reports the association between baseline pain and cognitive change between wave 2 and 
wave 4. After adjusting for 26 potential confounders, no association between pain and change in 
verbal fluency (0.02 points; 95%CI: -0.15 to 0.18; p=0.85), memory (0.05 points; 95%CI: -0.28 to 
0.38; p=0.77) or processing speed (0.55 points; 95%CI: -18.4 to 2.93; p=0.65) was found (Table 2). 
In a sensitivity analysis, we excluded comorbidities at baseline from the models since these can be a 
mediator in the pathway between pain and cognitive worsening and could potentially attenuate the 
association between pain and cognition. However, only a slight difference in results was observed 
in this sensitivity analysis and pain was not significantly associated with change in verbal fluency (-
0.009 points; 95%CI: -0.33 to 0.31; p=0.95), memory (-0.02 points; 95%CI: -0.18 to 0.15; p=0.85) 
or processing speed (-2.21 points; 95%CI: -7.85 to 4.25; p=0.57) (other details not shown).. 
 
Table 3 shows the association between pain (categorized according to its severity as mild, moderate 
or severe) and cognitive changes between wave 2 and 4. Taking people with no pain as the 
reference group and after adjusting our analyses for all the confounders mentioned before, the 
severity of pain was not associated with a decrease in performance on any cognitive tests, with the 
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exception of memory, where  severe pain was associated with a decline (-0.36 points; 95%CI: -0.68 
to -0.04; p=0.04).  
 
DISCUSSION 
In this study, involving a large sample of community-dwelling older people, we found that pain was 
associated with poorer performance on some cognitive tests cross-sectionally (at baseline), but not 
with significant changes in these scores after four years of follow-up. We also found that after 
adjustment for many potential confounders, previously significant associations disappeared.  
 
Previous literature reports that pain could be associated with cognitive dysfunction through several 
mechanisms. In a pivotal review regarding this issue[20], the authors reported that pre-clinical and 
clinical studies suggest three theories: (1) competing limited resources, (2) neuroplasticity and (3) 
dysregulated neurochemistry. Regarding the first point, it was hypothesized that pain may compete 
with other attention-demanding stimuli for limited cognitive resources.[21] Thus, the presence of 
pain stimuli may impair top-down attentional control mechanisms which filter out task-irrelevant 
stimuli, resulting in impaired task performance. [21]  Regarding the second point, as shown by 
neuroimaging studies, pain seems to be associated with a reduction of grey matter in the insular 
cortex and in neurogenesis in the hippocampus, two key structures for cognition.[21] Third, pain 
seems to be associated with an imbalance in several neurotransmitters, in particular a reduction in 
brain-derived neurotrophic factor (BDNF)[22], an increase in activity in the glutamate inhibitor 
pathway[23] and in GABA signaling[24], leading to a reduction in cognitive function. However, 
other factors, such as the use of analgesic medications, are probably important in explaining the 
association between pain and cognitive function.[20]    
 
Our results contrast with some previous literature on the relationship between pain and a worsening 
in cognitive function. Several cross-sectional studies reported a significant association between pain 
AC
CE
PT
ED
 M
AN
US
CR
IPT
11 
 
and cognitive function.[9-14] A large recent longitudinal study with more than 10,000 participants 
followed up for 10 years reported that pain at baseline was associated with an accelerated memory 
decline and increased risk for dementia.[15] A number of hypotheses can explain the differences 
between our research and previous papers. First, and probably more important, is the number and 
type of covariates used for adjusting the analyses. Indeed, we adjusted for 26 potential confounders, 
including physical comorbidities associated with pain, such as osteoporosis[25], arthritis[26], and 
cancer[27], which seem to be associated with poor cognitive performance, whilst previous studies 
adjusted only for some of these confounders. Thus, it is difficult to state whether pain per se or the 
comorbidities associated with pain are the risk factors for cognitive decline. However, a sensitivity 
analysis excluding comorbidities from the models showed that that results were largely unchanged. 
Second, the tests used for assessing cognitive function in previous papers were different from those 
used here. Third, compared with the largest work regarding this topic [15], we found a difference of 
about 8 years between our study and that study, which could  further influence our results. It is 
possible that results would have been different if we had used different cognitive function tests or if 
the follow-up time was longer. Finally, there may be an element of survival bias, where we 
excluded a considerable portion of people due to missing data at follow-up, who may have had 
worse cognitive function at baseline and higher prevalence of pain.  Unfortunately, during the 
course of longitudinal follow-up studies, many older participants drop out. When dropout is 
dependent on unknown or unmeasured parameters (as in our study), there is no easy solution for 
bias correction. [28] Thus, it is important to highlight that our results may be biased by this high 
rate of dropouts during follow-up period. 
 
Severe pain at baseline was associated with declines in memory test scores assessed through 
immediate and delayed word recall. However, the result was only marginally significant. Thus, this 
result should be interpreted with caution. The literature so far in both clinical and pre-clinical 
settings, in fact, has reported that pain reduced all aspects of cognitive function – those assessed in 
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our study (verbal fluency, memory and processing speed) as well as others (such as general 
cognition assessed through common tests like the mini-mental state examination).[9-15] However, 
the different tests used to assess cognitive function in previous studies and ours make direct 
comparisons difficult. Further studies are needed to assess whether our results can be replicated, and 
whether severe pain is more likely to be associated with cognitive decline in some domains (e.g., 
memory) than others. 
 
The findings of our study should be interpreted within their limitations. First, more than 3,000 
participants were lost to follow-up. These individuals were older and were more likely to have pain 
and perform poorly on cognitive tests. Thus, attrition bias may exist. It is also possible that people 
experiencing more pain at wave 2 died before showing any decrease in cognitive tests (survival 
bias). Second, pain was assessed only through two questions, and retrospectively, and information 
on the site of pain, the use of antalgics or its chronicity were not collected, and sophisticated tools 
for assessing pain (e.g. numerical rating scale) were not used. Third, due to the observational nature 
of our study, we cannot deduce the exact direction of effect of our findings. Finally, cognitive 
ability test scores in older people may reflect not only a possible decline, but also their peak prior 
cognitive ability[28], but we did not have any information regarding the trajectories of their 
cognitive function during the lifespan.    
 
In conclusion, our large study involving older community-dwelling participants suggests that 
cognitive decline may be more pronounced among those with pain, but only due to the presence of 
factors associated with both pain and poor cognition. Since pain could be treated with medications 
and other interventions, further studies are needed to better understand the association between pain 
and cognition in the elderly.  
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Figures and table 
 
 
Table 1. Baseline characteristics by presence or absence of pain.  
 
Variable 
Pain (+)  
(n=2317) 
Pain (-)  
(n=4198) 
p-value 
General characteristics    
Age (years) 65.5 (9.5) 64.2 (9.7) <0.0001 
Females (%) 53.7 63.7 <0.0001 
College and above (%) 17.1 9.3 <0.0001 
Married (%) 68.3 66.0 0.06 
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Variable 
Pain (+)  
(n=2317) 
Pain (-)  
(n=4198) 
p-value 
Alcohol drinking (%) 28.8 35.1 <0.0001 
Present/previous smokers (%) 60.0 64.8 <0.0001 
High physical activity level 
(%) 
24.3 14.9 <0.0001 
Disabled (%) 36.0 7.8 <0.0001 
Whites (%) 98.6 97.3 0.001 
Household wealth (£) 235,485±391,888 321,455±461,741 <0.0001 
Body mass index (Kg/m2) 29.1 (5.5) 27.4 (4.5) <0.0001 
Medical conditions    
Angina (%) 14.1 6.8 <0.0001 
Myocardial infarction (%) 7.1 4.5 0.001 
Heart failure (%) 1.8 0.7 0.007 
Arrhytmia (%) 12.3 6.7 <0.0001 
Arthritis (%)  65.0 25.4 <0.0001 
Osteoporosis (%) 12.1 4.1 <0.0001 
Stroke (%) 5.7 4.2 <0.0001 
Parkinson’s disease (%) 0.6 0.4 0.21 
Lung disease (%) 10.8 4.7 <0.0001 
Asthma (%) 12.5 11.1 <0.0001 
Cancer (%) 7.9 6.9 0.20 
Diabetes (%) 11.2 7.0 <0.0001 
High blood pressure (%) 52.5 38.1 <0.0001 
CESD (points) 2.2 (2.2) 1.1 (1.6) <0.0001 
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Variable 
Pain (+)  
(n=2317) 
Pain (-)  
(n=4198) 
p-value 
Cognitive tests (at wave 2)    
Verbal fluency 19.7 (6.4) 21.0 (6.5) <0.0001 
Memory 9.9 (3.7) 10.6 (3.5) <0.0001 
Processing speed 294 (105) 296 (98) 0.64 
Notes: Numbers are mean (standard deviations) or percentages as appropriate.  
Abbreviations: CESD: Center for Epidemiologic Studies Depression.
AC
CE
PT
ED
 M
AN
US
CR
IPT
19 
 
Table 2. Association between baseline presence of pain and change in scores of cognitive tests between wave 4 and 2.   
 
Notes: 
Unless otherwise specified, data are presented as betas and their 95% confidence intervals, using the standardized residuals at wave 4 as outcome.  
In all the elaborations, those with no pain at baseline were taken as reference. 
Basic-adjusted model included age (as continuous) and gender; fully-adjusted model includes, other than age and sex, baseline values of: race; 
educational level (as continuous variable); marital status (married vs. others); household wealth; activities of daily living score; CES-D score; body 
mass index; smoking habits (present/former vs. never); physical activity level; alcohol drinking (yes vs. no); presence at baseline of angina, 
myocardial infarction, heart failure, arrhythmia, stroke, arthritis, osteoporosis, Parkinson’s disease, lung disease, asthma, cancer, diabetes, high 
blood pressure (all yes vs. no); cognitive test values at wave 2.    
 Sample size Basic-adjusted 
beta 
(95%CI) 
p – 
value 
R2 
Fully-adjusted 
beta 
(95%CI) 
p – 
value 
R2 
Verbal fluency 6440 0.73 (0.52-0.93) <0.0001 0.10 0.02 (-0.15; 0.18) 0.85 0.51 
Memory 6440 1.43 (1.04-1.82) <0.0001 0.10 0.05 (-0.28; 0.38) 0.77 0.48 
Processing speed 6515 -1.50 (-3.73; 0.72) 0.19 0.00 0.55 (-18.4; 2.93) 0.65 0.19 
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Table 3. Association between baseline severity of pain and change in scores of cognitive tests between wave 4 and 2.   
 
 
Notes: 
Unless otherwise specified, data are presented as fully-adjusted betas and their 95% confidence intervals, using the standardized residuals at wave 4 
as outcome.  
In all the elaborations, those with no pain at baseline were taken as reference. 
Fully-adjusted model includes: age (as continuous); gender; race; educational level (as continuous variable); marital status (married vs. others); 
household wealth; activities of daily living score; CES-D score; body mass index; smoking habits (present/former vs. never); physical activity level; 
alcohol drinking (yes vs. no); presence at baseline of angina, myocardial infarction, heart failure, arrhythmia, stroke, arthritis, osteoporosis, 
Parkinson’s disease, lung disease, asthma, cancer, diabetes, high blood pressure (all yes vs. no); cognitive test values at wave 2.   
 No pain 
(n=4,198) 
Mild pain  
(n=697) 
p-value Moderate pain  
(n=1,166) 
p-value Severe pain 
(n=450) 
p-value 
Verbal fluency Reference 0.07 (-0.38; 0.53) 0.75 -0.18 (-0.58; 0.23) 0.39 0.06 (-0.57; 0.69) 0.85 
Memory Reference 0.02 (-0.22; 0.25) 0.89 0.05 (-0.16; 0.26) 0.63 -0.36 (-0.68; -0.04) 0.04 
Processing speed Reference 3.02 (-6.55; 12.59) 0.54 -0.08 (-8.53; 8.38) 0.99 0.82 (-12.32; 
13.95) 
0.90 
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